Filters
Need Help Planning Your Treatment Abroad?
Your 24/7 AI Health Assistant 
Commonly affecting children and young adults, rhabdomyosarcoma (RMS) is an uncommon and aggressive form of soft tissue cancer that arises in skeletal muscle cells. Treatment for rhabdomyosarcoma (RMS) includes radiation therapy to stop recurrence, chemotherapy to reduce or eradicate cancer cells, and surgery to remove the tumor. In certain situations, immunotherapy or targeted therapy may be employed. Rehabilitation and pain management are supportive care that enhances a patient's quality of life.
Rhabdomyosarcoma (RMS) is a rare cancer that develops from skeletal muscle cells. Treatment aims to kill cancer cells, stop the disease from spreading to other organs, alleviate symptoms, and maintain normal body function. Remission, decreased return risk, and improved longevity and quality of life are treatment goals, regardless of whether the tumour is contained or has spread, particularly in children and young adults, where RMS is more prevalent.
See a doctor if you experience symptoms like eye bulging or urinary issues, unexplained bleeding from body openings, pain in a particular place, or a quickly increasing lump or swelling. Early diagnosis greatly enhances treatment results. The experienced oncology staff at MediGence can help with timely assessment and individualised treatment.
Imaging tests such as MRIs, CT scans, PET scans, and biopsies confirm the diagnosis and RMS subtype (embryonal, alveolar, or other). Blood tests, lumbar punctures, and bone marrow biopsies are possible further procedures to determine the degree of dissemination. Your care team should be informed of your child's or your complete medical history, prescription drugs, and any lingering health conditions.
- Surgery: When possible, the tumour is cut out surgically to achieve full resection while maintaining function.
- Chemotherapy: Almost all patients receive chemotherapy, which helps treat microscopic illness, reduce tumour size, and stop its spread.
- Radiation Therapy: Radiation therapy is used in conjunction with chemotherapy and surgery, particularly in cases where complete surgical removal is not feasible.
- Targeted Therapy/Immunotherapy: Immunotherapy or targeted therapy may be applied to relapsed cases or certain genetic subgroups.
- Supportive Care: Supportive care includes pain control, nutritional assistance, psychiatric counselling, and infection control.
- Follow-up: Routine lab work and scans are required to track recurrence and treatment response.
RMS treatment usually lasts 6 to 12 months, with surgery requiring a short hospital stay and chemotherapy or radiation given over multiple sessions. Long-term recovery and monitoring may continue for several years.
- Metastasis or recurrence locally
- advanced stages of involvement of the brain, lungs, or bone marrow
- Stress on an emotional and psychological level, particularly in young patients
- Loss of hair
- Low blood counts increase the risk of infection.
- Possible long-term impacts on organ function, growth, and fertility
Treatment for RMS can result in long-term remission with a multidisciplinary approach, particularly in localised cases. Surgery removes visible tumours, radiation improves local control, and chemotherapy aids in the management of microscopic disease. Modern methods also seek to reduce long-term side effects and maintain organ function to ensure a higher quality of life after treatment.
The tumour site and level of treatment impact recovery. Wound care, physical therapy, and pain control are all part of post-surgery treatment. Routine monitoring is necessary to control side effects during radiation or chemotherapy. Physical examinations, imaging, and monitoring for late effects, such as hormonal or heart problems, are all part of long-term follow-up.
Alveolar and metastatic types of RMS have worse 5-year survival rates than localised embryonal RMS, which has a 70–90% survival rate. Treatment advancements, particularly in the areas of early detection and specialised care, have greatly enhanced results.
Would you like some help? We are available.
Get Help Explore Hospitals ( 2 )
Asan Medical Centre
Seoul, South Korea
Asan Medical Centre located in Seoul, South Korea is accredited by ISO. Also listed below are some of the most prominent infrastructural details:
- 524,700 square meters is the floor area of Asan Medical Centre
- Number of beds is 2,715
- 67 operating rooms
- 11,680 outpatients
- Everday 2,427 inpatients come to the Centre
- 66,838 Sophisticated surgeries (per year)
- 1,600 physicians and surgeons
- 3,100 nurses
- Five various types of rooms ranging from suites to multi-bed rooms
International St. Mary's Hospital
Seoul, South Korea
International St. Mary's Hospital located in Seoul, South Korea is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- 3 Basements and 5 Floors Building
- International Healthcare Center
- Korean Traditional Medicine Hospital
- Hybrid Operation Theatres
- Conference Rooms
- Seminar Rooms
- Auditorium
- Intensive Care Units
- Hospice ward
- Chapel
- Emergency Medical Center
- Pathology
- Outpatient Pharmacy
- 15 Professional Treatment Centers
- 35 Clinical Departments
- Transplant Centers
- Admission & Discharge Center
- Counseling office
- Convenience Store
- Animal Laboratories
- Parking in basement
- Food court for patients & visitors
- Coffee Shop
- Free Wi-fi is available throughout the Hospital premises
Need Some Advice From Our Experts?
Request a Call Back Now!
Our team of healthcare experts would be happy to assist you
+99
